Absorption |
Blood-Brain Barrier | BBB+ | 0.9936 |
Human Intestinal Absorption | HIA+ | 0.9658 |
Caco-2 Permeability | Caco2+ | 0.7732 |
P-glycoprotein Substrate | Substrate | 0.8196 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7107 |
Non-inhibitor | 0.6358 |
Renal Organic Cation Transporter | Inhibitor | 0.7028 |
Distribution |
Subcellular localization | Mitochondria | 0.6734 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8375 |
CYP450 2D6 Substrate | Substrate | 0.6687 |
CYP450 3A4 Substrate | Substrate | 0.5878 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.5841 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9068 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.6001 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8442 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8521 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6184 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6340 |
Non-inhibitor | 0.6931 |
AMES Toxicity | Non AMES toxic | 0.8365 |
Carcinogens | Non-carcinogens | 0.9554 |
Fish Toxicity | High FHMT | 0.9429 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8030 |
Honey Bee Toxicity | Low HBT | 0.5867 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.5530 |
Carcinogenicity (Three-class) | Non-required | 0.5835 |